SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-208791
Filing Date
2022-08-01
Accepted
2022-08-01 16:45:19
Documents
17
Period of Report
2022-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385263d8k.htm   iXBRL 8-K 28627
2 EX-99.1 d385263dex991.htm EX-99.1 101127
7 GRAPHIC g385263g0729220429796.jpg GRAPHIC 7806
8 GRAPHIC g385263g15t02.jpg GRAPHIC 9152
9 GRAPHIC g385263g77l89.jpg GRAPHIC 9870
  Complete submission text file 0001193125-22-208791.txt   339898

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20220801.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20220801_def.xml EX-101.DEF 13821
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20220801_lab.xml EX-101.LAB 22922
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20220801_pre.xml EX-101.PRE 14701
11 EXTRACTED XBRL INSTANCE DOCUMENT d385263d8k_htm.xml XML 5556
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 221125425
SIC: 2836 Biological Products, (No Diagnostic Substances)